Anti-HPGD antibody (1-266) (STJ29006)
SPECIFICATIONS
ClonalityPolyclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG
General Information
| Short Description | Rabbit polyclonal HPGD (1-266) antibody for use in WB and ELISA in human, mouse and rat samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | WB/ELISA |
| Host | Rabbit |
| Reactivity | Human/Mouse/Rat |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugation | Unconjugated |
| Concentration | Lot specific |
| Purification | Affinity purification |
| Dilution Range | WB:1:500-1:2000ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
| Formulation | PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. |
| Storage Instruction | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Target Information
| Gene Symbol | HPGD |
| Gene ID | 3248 |
| Uniprot ID | PGDH_HUMAN |
| Immunogen Region | 1-266 |
| Immunogen Sequence | MHVNGKVALVTGAAQGIGRA FAEALLLKGAKVALVDWNLE AGVQCKAALDEQFEPQKTLF IQCDVADQQQLRDTFRKVVD HFGRLDILVNNAGVNNEKNW EKTLQINLVSVISGTYLGLD YMSKQNGGEGGIIINMSSLA GLMPVAQQPVYCASKHGIVG FTRSAALAANLMNSGVRLNA ICPGFVNTAILESIEKEENM GQYIEYKDHIKDMIKYYGIL DPPLIANGLITLIEDDALN |
| Specificity | Recombinant fusion protein containing a sequence corresponding to amino acids 1-266 of human 15-PGDH/15-PGDH/HPGD (NP_000851.2). |
Additional Info
| Tissue Specificity | Detected in colon epithelium (at protein level). |
| Function | Catalyzes the NAD-dependent dehydrogenation (oxidation) of a broad array of hydroxylated polyunsaturated fatty acids (mainly eicosanoids and docosanoids, including prostaglandins, lipoxins and resolvins), yielding their corresponding keto (oxo) metabolites. Decreases the levels of the pro-proliferative prostaglandins such as prostaglandin E2 (whose activity is increased in cancer because of an increase in the expression of cyclooxygenase 2) and generates oxo-fatty acid products that can profoundly influence cell function by abrogating pro-inflammatory cytokine expression. Converts resolvins E1, D1 and D2 to their oxo products, which represents a mode of resolvin inactivation. Resolvin E1 plays important roles during the resolution phase of acute inflammation, while resolvins D1 and D2 have a unique role in obesity-induced adipose inflammation. |
| Protein Name | 15-Hydroxyprostaglandin Dehydrogenase Nad(+15-PgdhEicosanoid/Docosanoid Dehydrogenase Nad(+Prostaglandin Dehydrogenase 1Short Chain Dehydrogenase/Reductase Family 36c Member 1 |
| Database Links | Reactome: R-HSA-2142700Reactome: R-HSA-2162123Reactome: R-HSA-9018676Reactome: R-HSA-9018896 |
| Cellular Localisation | Cytoplasm |
| Alternative Antibody Names | Anti-15-Hydroxyprostaglandin Dehydrogenase Nad(+ antibodyAnti-15-Pgdh antibodyAnti-Eicosanoid/Docosanoid Dehydrogenase Nad(+ antibodyAnti-Prostaglandin Dehydrogenase 1 antibodyAnti-Short Chain Dehydrogenase/Reductase Family 36c Member 1 antibodyAnti-HPGD antibodyAnti-PGDH1 antibodyAnti-SDR36C1 antibody |
Information sourced from Uniprot.org